Dr. Reddy's Laboratories Limited has grown revenue 15% a year over three years and 13% a year over five, with earnings per share compounding at 34%. Revenue growth, 3-year annual rate: +15% (Drug Manufacturers - Specialty & Generic median +13%). Revenue growth, 5-year rate: +13%, growth has picked up over the last three years. Earnings per share, 3-year rate: +34%, earnings outgrew revenue: margins or the share count worked for shareholders. Years of annual history on file: 10, FY2016 to FY2025, as filed.

RDYDr. Reddy's Laboratories Limited

Healthcare

$12.46-16% 1Y

$12.46

$11.4052 weeks$15.25

Is it growing?

Good

Growing: revenue growing +17% year on year and operating margin widening (+9.3 points).

2 good, 1 neutral

Revenue trend+17% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +13% a year.

Earnings trend+1% in a year

Trailing-twelve-month earnings per share against a year earlier. Growing slower than revenue, so the growth is costing something.

Margin direction+9.3 points operating

Trailing-twelve-month operating margin, 22.1% now against 12.8% a year earlier.

All from SEC EDGAR, as of Mar 31, 2025.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is RDY growing?

Dr. Reddy's Laboratories Limited has grown revenue 15% a year over three years and 13% a year over five, with earnings per share compounding at 34%.

+15%

Revenue growth, 3-year annual rate · Drug Manufacturers - Specialty & Generic median +13% · steady growth, ahead of inflation · compounded from fiscal years as filed

Revenue growth, 5-year rate: +13%
Revenue growth, 5-year rate · +15% over three · growth has picked up over the last three years
Earnings per share, 3-year rate: +34%
Earnings per share, 3-year rate · revenue +15% · earnings outgrew revenue: margins or the share count worked for shareholders
Years of annual history on file: 10
Years of annual history on file · FY2016 to FY2025, as filed